Silencing ANXA3 suppresses the NFκB pathway via upregulating IκBα, leading to mesenchymal-epithelial transition (MET) with attenuated invasion and metastasis, but promotes tumor cell proliferation. Here, NFKBIA is linked to neoplasm.